Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

$960 Billion Proteins & Protein Crystals Market Outlook, 2030 | High Investment and Funding in Structural Biology, Biopharmaceuticals, and Advanced Drug Development

globenewswire.com
DHR Danaher is listed as a key market player in the proteins and protein crystals market, which is experiencing significant growth. The article does not provide specific sentiment towards Danaher itself. TMO Thermo Fisher Scientific is identified as a key market player in the growing proteins and protein crystals sector. The article does not offer specific sentiment details for the company. IFF International Flavours and Fragrances is listed as a key player in the proteins and protein crystals market. The article does not provide specific sentiment or outlook for the company. AMGN Amgen is identified as a key market player within the proteins and protein crystals industry. The article does not express a specific sentiment towards Amgen. LLY Eli Lilly is named as a key company in the proteins and protein crystals market. The article does not provide specific sentiment or forward-looking statements for the company. PFE Pfizer is listed as a key market player in the proteins and protein crystals sector. The article does not provide specific sentiment or detailed analysis for Pfizer.

$960 Billion Proteins & Protein Crystals Market Outlook, 2030 | High Investment and Funding in Structural Biology, Biopharmaceuticals, and Advanced Drug Development Dublin, June 25, 2026 (GLOBE NEWSWIRE) -- The "Proteins & Protein Crystals Market by Product Type, Structural, Specialty, Application, End User - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering.

The global protein and protein crystals market is anticipated to reach USD 960.37 billion by 2030, up from USD 609.51 billion in 2025, reflecting a CAGR of 9.5% between 2025 and 2030. Key industry drivers include the increasing demand for biopharmaceuticals, heightened R&D in structural biology and drug discovery, and expanding applications for proteins in diagnostics, therapeutics, and industrial sectors.

Enzymatic proteins dominate the market due to their extensive use in therapeutics, industrial biocatalysis, and high-throughput screening. Additionally, recombinant and monoclonal proteins are gaining traction in drug development and personalized medicine for their specificity and scalability.

The growing popularity of protein crystallization kits, reagents, and automated crystallization platforms for structural studies fuels market growth. Researchers and pharmaceutical firms leverage these tools for determining protein structures, expediting drug design, and enhancing enzyme-based industrial processes.

Structural Proteins Segment Leading Growth

The structural proteins segment is expected to record the highest CAGR during the forecast period. This growth is propelled by demand from research, healthcare, and industrial arenas. Proteins such as actin and tubulin are crucial in structural biology, high-throughput crystallography, and drug discovery. Membrane proteins emerge as key therapeutic targets in developing biologics and precision medicine. Moreover, connective tissue and extracellular matrix proteins-like collagen, elastin, laminins, and proteoglycans-drive demand in biomaterials, tissue engineering, regenerative medicine, and cosmetic products.

Healthcare Segment Dominates

The healthcare application segment accounts for the highest CAGR, linked to rising demand for therapeutic proteins, monoclonal antibodies, vaccines, and diagnostic enzymes. The prevalence of chronic diseases, cancer, and metabolic disorders spurs the development of protein-based biologics. Advances in structural biology and protein crystallography accelerate drug discovery and targeted therapy.

Rapid Growth in Asia Pacific

The Asia Pacific region is set to exhibit the highest CAGR, fueled by robust growth across healthcare, research, and various other applications. Growing biopharmaceutical R&D, a rise in chronic disease cases, and the adoption of personalized medicine drive demand for therapeutic proteins, monoclonal antibodies, and protein-based diagnostics in healthcare. Enhanced life sciences infrastructure, Contract Research Organizations (CROs), and structural biology undertakings boost protein crystallization kit and reagent usage in research and academia.

Additional applications contribute to market expansion in areas such as agriculture and animal health-utilizing proteins for feed additives, vaccines, and disease management-and cosmetics, where structural proteins like collagen and elastin feature in anti-aging and skincare products. In bioenergy, enzymes facilitate biomass conversion and biofuel production, collectively contributing to rapid market growth in the Asia Pacific.

Research Insights

The market is segmented by product type, application, end-user, and region. The report delves into significant factors such as driving forces, restraints, and opportunities impacting stakeholders. It evaluates key organizations within the protein and protein crystals market, offers micro-level analysis for market trends, and identifies growth opportunities through revenue segmentation in major regions.

Key market players include Danaher (US), Thermo Fisher Scientific Inc. (US), Sanofi (France), Agilent (US), Takeda Pharmaceutical Company (Japan), International Flavours and Fragrances (US), Biocon (India), RayBiotech (US), Merck KGaA (Germany), Amgen (US), Eli Lilly (US), Roche (Switzerland), Novo Nordisk (Denmark), and Pfizer (US), among others.

Key Attributes

Market Dynamics

Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/dazg1q

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment